date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.477137395905592.
The log-likelihood improved by 3.088.
Iteration 2 of at most 500:
Optimizing with step length 0.800727497813229.
The log-likelihood improved by 2.62.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4181.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.2375.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       16     1220      997      793      363      384      379 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     303      216      157       79       36       27       13        8 
degree16 degree17 degree18 
       3        3        1 
1 
disease_progression 
H-positive risk:  869 894 123 888 422 121 869 451 121 60 118 64 
H-negative risk:  894 869 869 888 451 422 121 123 118 121 64 60 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 1 2 

clinical_engagement 
diagnosis 
demography 
52 new agents 
2 
disease_progression 
H-positive risk:  874 902 125 881 422 122 866 448 120 59 118 63 
H-negative risk:  902 874 866 881 448 422 122 125 118 120 63 59 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 3 3 

clinical_engagement 
diagnosis 
demography 
66 new agents 
3 
disease_progression 
H-positive risk:  885 905 123 886 416 122 859 443 120 59 120 62 
H-negative risk:  905 885 859 886 443 416 122 123 120 120 62 59 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 7 3 

clinical_engagement 
diagnosis 
demography 
65 new agents 
4 
disease_progression 
H-positive risk:  890 910 124 885 405 123 858 446 119 60 121 59 
H-negative risk:  910 890 858 885 446 405 123 124 121 119 59 60 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
62 new agents 
5 
disease_progression 
H-positive risk:  891 913 124 881 403 125 857 446 119 60 121 60 
H-negative risk:  913 891 857 881 446 403 125 124 121 119 60 60 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 10 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
6 
disease_progression 
H-positive risk:  895 921 126 877 403 125 858 439 117 57 123 59 
H-negative risk:  921 895 858 877 439 403 125 126 123 117 59 57 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 11 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
7 
disease_progression 
H-positive risk:  896 925 127 872 410 128 849 437 118 56 124 58 
H-negative risk:  925 896 849 872 437 410 128 127 124 118 58 56 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 13 4 

clinical_engagement 
diagnosis 
demography 
61 new agents 
8 
disease_progression 
H-positive risk:  904 928 126 870 407 130 853 432 116 55 122 57 
H-negative risk:  928 904 853 870 432 407 130 126 122 116 57 55 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 15 5 

clinical_engagement 
diagnosis 
demography 
52 new agents 
9 
disease_progression 
H-positive risk:  901 931 130 869 402 130 856 431 116 54 123 57 
H-negative risk:  931 901 856 869 431 402 130 130 123 116 57 54 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 18 5 

clinical_engagement 
diagnosis 
demography 
59 new agents 
10 
disease_progression 
H-positive risk:  904 935 129 873 397 130 852 428 117 54 124 57 
H-negative risk:  935 904 852 873 428 397 130 129 124 117 57 54 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 23 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
11 
disease_progression 
H-positive risk:  909 945 130 865 391 132 854 425 117 55 122 55 
H-negative risk:  945 909 854 865 425 391 132 130 122 117 55 55 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 24 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
12 
disease_progression 
H-positive risk:  922 943 128 867 388 131 850 424 114 56 124 53 
H-negative risk:  943 922 850 867 424 388 131 128 124 114 53 56 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 26 6 

clinical_engagement 
diagnosis 
demography 
59 new agents 
13 
disease_progression 
H-positive risk:  847 867 117 942 382 125 934 423 122 54 134 53 
H-negative risk:  867 847 934 942 423 382 125 117 134 122 53 54 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
204 new agents 
14 
disease_progression 
H-positive risk:  866 892 126 901 392 129 876 459 115 55 131 58 
H-negative risk:  892 866 876 901 459 392 129 126 131 115 58 55 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 31 7 

clinical_engagement 
diagnosis 
demography 
70 new agents 
15 
disease_progression 
H-positive risk:  882 888 127 893 391 129 873 456 116 55 131 59 
H-negative risk:  888 882 873 893 456 391 129 127 131 116 59 55 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 33 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
16 
disease_progression 
H-positive risk:  885 898 125 890 388 131 872 454 115 51 131 60 
H-negative risk:  898 885 872 890 454 388 131 125 131 115 60 51 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 35 7 

clinical_engagement 
diagnosis 
demography 
57 new agents 
17 
disease_progression 
H-positive risk:  888 901 125 896 378 132 873 451 116 52 129 59 
H-negative risk:  901 888 873 896 451 378 132 125 129 116 59 52 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 38 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
18 
disease_progression 
H-positive risk:  892 899 128 908 379 132 869 440 114 52 129 58 
H-negative risk:  899 892 869 908 440 379 132 128 129 114 58 52 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 39 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
19 
disease_progression 
H-positive risk:  905 907 128 906 370 134 863 440 113 49 129 56 
H-negative risk:  907 905 863 906 440 370 134 128 129 113 56 49 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 39 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
20 
disease_progression 
H-positive risk:  909 911 133 906 371 135 861 430 113 47 129 55 
H-negative risk:  911 909 861 906 430 371 135 133 129 113 55 47 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 38 10 

clinical_engagement 
diagnosis 
demography 
50 new agents 
21 
disease_progression 
H-positive risk:  907 917 132 899 372 134 860 433 113 48 132 53 
H-negative risk:  917 907 860 899 433 372 134 132 132 113 53 48 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 40 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
22 
disease_progression 
H-positive risk:  914 915 133 900 368 132 863 427 113 48 134 53 
H-negative risk:  915 914 863 900 427 368 132 133 134 113 53 48 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 42 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
23 
disease_progression 
H-positive risk:  924 917 131 891 373 132 859 424 115 48 134 52 
H-negative risk:  917 924 859 891 424 373 132 131 134 115 52 48 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 43 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
24 
disease_progression 
H-positive risk:  919 924 133 887 373 131 860 422 116 49 134 52 
H-negative risk:  924 919 860 887 422 373 131 133 134 116 52 49 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 45 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
25 
disease_progression 
H-positive risk:  846 851 123 957 370 118 936 423 130 49 144 53 
H-negative risk:  851 846 936 957 423 370 118 123 144 130 53 49 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 47 16 

clinical_engagement 
diagnosis 
demography 
173 new agents 
26 
disease_progression 
H-positive risk:  862 868 121 922 387 122 902 440 131 49 136 60 
H-negative risk:  868 862 902 922 440 387 122 121 136 131 60 49 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 46 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
27 
disease_progression 
H-positive risk:  860 875 125 922 383 125 904 432 128 50 136 60 
H-negative risk:  875 860 904 922 432 383 125 125 136 128 60 50 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 44 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
28 
disease_progression 
H-positive risk:  866 876 126 923 384 124 901 430 126 49 135 60 
H-negative risk:  876 866 901 923 430 384 124 126 135 126 60 49 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 42 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  871 884 129 924 382 122 899 426 124 49 133 57 
H-negative risk:  884 871 899 924 426 382 122 129 133 124 57 49 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 44 16 

clinical_engagement 
diagnosis 
demography 
51 new agents 
30 
disease_progression 
H-positive risk:  879 880 127 922 384 122 900 426 124 48 132 56 
H-negative risk:  880 879 900 922 426 384 122 127 132 124 56 48 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 47 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
31 
disease_progression 
H-positive risk:  882 884 128 919 384 124 899 424 123 49 131 53 
H-negative risk:  884 882 899 919 424 384 124 128 131 123 53 49 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 48 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  893 883 130 920 380 122 895 418 125 50 131 53 
H-negative risk:  883 893 895 920 418 380 122 130 131 125 53 50 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 48 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
33 
disease_progression 
H-positive risk:  898 886 129 916 379 123 889 416 129 52 131 52 
H-negative risk:  886 898 889 916 416 379 123 129 131 129 52 52 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 50 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
34 
disease_progression 
H-positive risk:  903 886 133 916 377 122 884 414 126 54 132 53 
H-negative risk:  886 903 884 916 414 377 122 133 132 126 53 54 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 52 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
35 
disease_progression 
H-positive risk:  911 882 133 915 372 122 888 411 131 52 130 53 
H-negative risk:  882 911 888 915 411 372 122 133 130 131 53 52 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 51 14 

clinical_engagement 
diagnosis 
demography 
57 new agents 
36 
disease_progression 
H-positive risk:  913 880 130 917 369 122 889 412 132 54 129 53 
H-negative risk:  880 913 889 917 412 369 122 130 129 132 53 54 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 52 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
37 
disease_progression 
H-positive risk:  862 808 128 985 365 111 956 406 142 54 129 54 
H-negative risk:  808 862 956 985 406 365 111 128 129 142 54 54 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 52 12 

clinical_engagement 
diagnosis 
demography 
158 new agents 
38 
disease_progression 
H-positive risk:  882 824 131 966 378 110 925 414 138 58 117 57 
H-negative risk:  824 882 925 966 414 378 110 131 117 138 57 58 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 50 12 

clinical_engagement 
diagnosis 
demography 
77 new agents 
39 
disease_progression 
H-positive risk:  873 831 132 961 388 107 930 414 139 53 115 57 
H-negative risk:  831 873 930 961 414 388 107 132 115 139 57 53 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 48 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
40 
disease_progression 
H-positive risk:  872 837 130 963 383 109 930 411 141 52 114 58 
H-negative risk:  837 872 930 963 411 383 109 130 114 141 58 52 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 47 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
41 
disease_progression 
H-positive risk:  881 838 130 972 380 111 926 401 142 52 112 55 
H-negative risk:  838 881 926 972 401 380 111 130 112 142 55 52 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 49 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
42 
disease_progression 
H-positive risk:  878 846 129 971 375 114 925 403 143 50 111 55 
H-negative risk:  846 878 925 971 403 375 114 129 111 143 55 50 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 53 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
43 
disease_progression 
H-positive risk:  877 848 126 970 375 113 934 403 140 50 108 56 
H-negative risk:  848 877 934 970 403 375 113 126 108 140 56 50 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 54 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
44 
disease_progression 
H-positive risk:  876 848 126 979 370 113 929 401 142 50 109 57 
H-negative risk:  848 876 929 979 401 370 113 126 109 142 57 50 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 54 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
45 
disease_progression 
H-positive risk:  887 855 126 972 369 115 924 398 139 48 110 57 
H-negative risk:  855 887 924 972 398 369 115 126 110 139 57 48 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 55 13 

clinical_engagement 
diagnosis 
demography 
57 new agents 
46 
disease_progression 
H-positive risk:  885 858 126 970 372 117 923 396 137 50 108 58 
H-negative risk:  858 885 923 970 396 372 117 126 108 137 58 50 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 54 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
47 
disease_progression 
H-positive risk:  885 864 126 972 368 118 921 393 137 49 109 58 
H-negative risk:  864 885 921 972 393 368 118 126 109 137 58 49 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 55 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
48 
disease_progression 
H-positive risk:  881 868 129 975 367 120 926 385 135 49 107 58 
H-negative risk:  868 881 926 975 385 367 120 129 107 135 58 49 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 56 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
49 
disease_progression 
H-positive risk:  837 814 129 1021 369 109 980 379 144 49 110 59 
H-negative risk:  814 837 980 1021 379 369 109 129 110 144 59 49 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 54 12 

clinical_engagement 
diagnosis 
demography 
157 new agents 
50 
disease_progression 
H-positive risk:  849 820 125 999 387 110 953 396 143 47 117 54 
H-negative risk:  820 849 953 999 396 387 110 125 117 143 54 47 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 56 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
51 
disease_progression 
H-positive risk:  843 820 125 1001 385 109 957 396 144 48 121 51 
H-negative risk:  820 843 957 1001 396 385 109 125 121 144 51 48 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 57 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  845 821 125 1002 387 110 962 390 144 44 120 50 
H-negative risk:  821 845 962 1002 390 387 110 125 120 144 50 44 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 60 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
53 
disease_progression 
H-positive risk:  854 824 126 1003 380 108 960 386 145 44 120 50 
H-negative risk:  824 854 960 1003 386 380 108 126 120 145 50 44 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 59 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
54 
disease_progression 
H-positive risk:  854 826 130 1006 374 109 956 386 143 44 120 52 
H-negative risk:  826 854 956 1006 386 374 109 130 120 143 52 44 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 60 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
55 
disease_progression 
H-positive risk:  858 821 129 1012 364 109 957 385 143 45 122 55 
H-negative risk:  821 858 957 1012 385 364 109 129 122 143 55 45 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 62 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
56 
disease_progression 
H-positive risk:  851 823 132 1014 368 107 959 384 144 44 119 55 
H-negative risk:  823 851 959 1014 384 368 107 132 119 144 55 44 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 62 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
57 
disease_progression 
H-positive risk:  856 824 134 1011 367 107 963 383 142 42 118 53 
H-negative risk:  824 856 963 1011 383 367 107 134 118 142 53 42 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 63 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
58 
disease_progression 
H-positive risk:  860 827 135 1012 366 107 963 378 141 42 117 52 
H-negative risk:  827 860 963 1012 378 366 107 135 117 141 52 42 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 65 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
59 
disease_progression 
H-positive risk:  865 822 137 1017 361 106 963 378 141 42 115 53 
H-negative risk:  822 865 963 1017 378 361 106 137 115 141 53 42 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 66 12 

clinical_engagement 
diagnosis 
demography 
83 new agents 
60 
disease_progression 
H-positive risk:  868 823 137 1003 357 110 970 379 139 43 116 55 
H-negative risk:  823 868 970 1003 379 357 110 137 116 139 55 43 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 66 12 

clinical_engagement 
diagnosis 
demography 
54 new agents 
61 
disease_progression 
H-positive risk:  815 775 129 1057 353 110 1021 379 140 41 125 55 
H-negative risk:  775 815 1021 1057 379 353 110 129 125 140 55 41 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 69 13 

clinical_engagement 
diagnosis 
demography 
112 new agents 
62 
disease_progression 
H-positive risk:  818 778 126 1043 365 110 997 398 138 43 127 57 
H-negative risk:  778 818 997 1043 398 365 110 126 127 138 57 43 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 68 11 

clinical_engagement 
diagnosis 
demography 
69 new agents 
63 
disease_progression 
H-positive risk:  817 785 125 1041 368 108 1001 390 135 44 130 56 
H-negative risk:  785 817 1001 1041 390 368 108 125 130 135 56 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 69 11 

clinical_engagement 
diagnosis 
demography 
82 new agents 
64 
disease_progression 
H-positive risk:  817 789 126 1042 362 108 1001 394 134 44 127 56 
H-negative risk:  789 817 1001 1042 394 362 108 126 127 134 56 44 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 69 13 

clinical_engagement 
diagnosis 
demography 
80 new agents 
65 
disease_progression 
H-positive risk:  821 788 126 1043 358 112 994 392 137 43 130 56 
H-negative risk:  788 821 994 1043 392 358 112 126 130 137 56 43 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
66 new agents 
66 
disease_progression 
H-positive risk:  816 797 127 1043 362 110 993 384 138 43 132 55 
H-negative risk:  797 816 993 1043 384 362 110 127 132 138 55 43 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 70 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
67 
disease_progression 
H-positive risk:  818 804 128 1039 366 109 985 379 138 43 135 56 
H-negative risk:  804 818 985 1039 379 366 109 128 135 138 56 43 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 72 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
68 
disease_progression 
H-positive risk:  827 809 126 1024 367 108 988 377 140 41 137 56 
H-negative risk:  809 827 988 1024 377 367 108 126 137 140 56 41 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
69 
disease_progression 
H-positive risk:  831 811 123 1021 366 108 994 377 136 42 137 54 
H-negative risk:  811 831 994 1021 377 366 108 123 137 136 54 42 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
70 
disease_progression 
H-positive risk:  835 820 117 1012 368 109 990 377 135 39 144 54 
H-negative risk:  820 835 990 1012 377 368 109 117 144 135 54 39 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
71 
disease_progression 
H-positive risk:  837 828 117 1003 362 107 991 378 137 42 144 54 
H-negative risk:  828 837 991 1003 378 362 107 117 144 137 54 42 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
72 
disease_progression 
H-positive risk:  843 835 115 999 360 108 986 377 138 42 143 54 
H-negative risk:  835 843 986 999 377 360 108 115 143 138 54 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
73 
disease_progression 
H-positive risk:  783 797 103 1042 360 102 1041 380 146 42 151 53 
H-negative risk:  797 783 1041 1042 380 360 102 103 151 146 53 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
106 new agents 
74 
disease_progression 
H-positive risk:  788 791 108 1039 362 106 1022 394 142 42 149 57 
H-negative risk:  791 788 1022 1039 394 362 106 108 149 142 57 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
75 
disease_progression 
H-positive risk:  791 794 112 1036 357 108 1018 396 139 42 148 59 
H-negative risk:  794 791 1018 1036 396 357 108 112 148 139 59 42 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
76 
disease_progression 
H-positive risk:  791 793 112 1030 362 110 1018 395 140 41 148 60 
H-negative risk:  793 791 1018 1030 395 362 110 112 148 140 60 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
77 
disease_progression 
H-positive risk:  795 794 115 1026 359 112 1027 389 138 40 148 57 
H-negative risk:  794 795 1027 1026 389 359 112 115 148 138 57 40 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
78 
disease_progression 
H-positive risk:  797 792 113 1024 362 106 1036 382 138 44 151 55 
H-negative risk:  792 797 1036 1024 382 362 106 113 151 138 55 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
79 
disease_progression 
H-positive risk:  798 794 112 1018 360 109 1034 382 139 44 153 57 
H-negative risk:  794 798 1034 1018 382 360 109 112 153 139 57 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
80 
disease_progression 
H-positive risk:  797 794 113 1017 355 109 1038 385 138 46 151 57 
H-negative risk:  794 797 1038 1017 385 355 109 113 151 138 57 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
81 
disease_progression 
H-positive risk:  795 785 118 1019 360 110 1035 382 140 47 150 59 
H-negative risk:  785 795 1035 1019 382 360 110 118 150 140 59 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
82 
disease_progression 
H-positive risk:  794 784 118 1019 356 115 1039 377 141 46 149 62 
H-negative risk:  784 794 1039 1019 377 356 115 118 149 141 62 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
83 
disease_progression 
H-positive risk:  791 786 119 1015 354 115 1049 373 140 48 146 64 
H-negative risk:  786 791 1049 1015 373 354 115 119 146 140 64 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
84 
disease_progression 
H-positive risk:  788 789 121 1011 355 115 1043 377 138 50 149 64 
H-negative risk:  789 788 1043 1011 377 355 115 121 149 138 64 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
85 
disease_progression 
H-positive risk:  740 733 116 1063 356 107 1103 373 142 49 156 62 
H-negative risk:  733 740 1103 1063 373 356 107 116 156 142 62 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
96 new agents 
86 
disease_progression 
H-positive risk:  747 734 116 1053 364 107 1088 385 136 54 154 62 
H-negative risk:  734 747 1088 1053 385 364 107 116 154 136 62 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
87 
disease_progression 
H-positive risk:  740 736 117 1055 365 108 1085 389 134 55 156 60 
H-negative risk:  736 740 1085 1055 389 365 108 117 156 134 60 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
88 
disease_progression 
H-positive risk:  736 737 117 1054 368 110 1091 379 137 57 154 60 
H-negative risk:  737 736 1091 1054 379 368 110 117 154 137 60 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
89 
disease_progression 
H-positive risk:  738 742 117 1053 367 108 1089 377 138 55 155 61 
H-negative risk:  742 738 1089 1053 377 367 108 117 155 138 61 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
90 
disease_progression 
H-positive risk:  748 746 117 1047 365 108 1081 384 141 53 152 58 
H-negative risk:  746 748 1081 1047 384 365 108 117 152 141 58 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
91 
disease_progression 
H-positive risk:  745 751 115 1049 363 107 1091 382 142 49 149 57 
H-negative risk:  751 745 1091 1049 382 363 107 115 149 142 57 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
92 
disease_progression 
H-positive risk:  758 755 113 1042 361 105 1093 376 144 50 151 52 
H-negative risk:  755 758 1093 1042 376 361 105 113 151 144 52 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
93 
disease_progression 
H-positive risk:  756 752 114 1049 362 108 1089 373 143 50 152 52 
H-negative risk:  752 756 1089 1049 373 362 108 114 152 143 52 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
94 
disease_progression 
H-positive risk:  751 752 115 1048 364 106 1097 369 141 52 153 52 
H-negative risk:  752 751 1097 1048 369 364 106 115 153 141 52 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
95 
disease_progression 
H-positive risk:  749 746 119 1051 369 104 1101 364 141 51 151 54 
H-negative risk:  746 749 1101 1051 364 369 104 119 151 141 54 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
96 
disease_progression 
H-positive risk:  750 751 121 1040 374 104 1101 365 140 52 150 52 
H-negative risk:  751 750 1101 1040 365 374 104 121 150 140 52 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
97 
disease_progression 
H-positive risk:  712 705 112 1081 374 103 1142 368 145 51 159 48 
H-negative risk:  705 712 1142 1081 368 374 103 112 159 145 48 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
100 new agents 
98 
disease_progression 
H-positive risk:  709 713 113 1067 386 102 1125 385 142 56 160 42 
H-negative risk:  713 709 1125 1067 385 386 102 113 160 142 42 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
99 
disease_progression 
H-positive risk:  712 714 113 1063 393 104 1118 387 138 56 159 43 
H-negative risk:  714 712 1118 1063 387 393 104 113 159 138 43 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
100 
disease_progression 
H-positive risk:  711 722 114 1055 399 103 1120 383 136 56 159 42 
H-negative risk:  722 711 1120 1055 383 399 103 114 159 136 42 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
101 
disease_progression 
H-positive risk:  711 718 117 1050 403 101 1122 383 137 57 158 43 
H-negative risk:  718 711 1122 1050 383 403 101 117 158 137 43 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
102 
disease_progression 
H-positive risk:  711 721 118 1057 404 99 1118 378 136 56 158 44 
H-negative risk:  721 711 1118 1057 378 404 99 118 158 136 44 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
103 
disease_progression 
H-positive risk:  716 718 116 1060 395 100 1122 371 147 56 159 40 
H-negative risk:  718 716 1122 1060 371 395 100 116 159 147 40 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
104 
disease_progression 
H-positive risk:  719 714 114 1066 398 101 1119 371 144 58 157 39 
H-negative risk:  714 719 1119 1066 371 398 101 114 157 144 39 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
105 
disease_progression 
H-positive risk:  722 720 115 1066 390 102 1117 371 144 56 158 39 
H-negative risk:  720 722 1117 1066 371 390 102 115 158 144 39 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
106 
disease_progression 
H-positive risk:  727 724 118 1061 389 106 1121 366 144 49 154 41 
H-negative risk:  724 727 1121 1061 366 389 106 118 154 144 41 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
107 
disease_progression 
H-positive risk:  732 722 121 1058 396 106 1115 362 144 46 158 40 
H-negative risk:  722 732 1115 1058 362 396 106 121 158 144 40 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
108 
disease_progression 
H-positive risk:  737 717 120 1062 397 107 1115 361 144 44 158 38 
H-negative risk:  717 737 1115 1062 361 397 107 120 158 144 38 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
109 
disease_progression 
H-positive risk:  691 679 113 1102 391 101 1166 363 147 42 165 40 
H-negative risk:  679 691 1166 1102 363 391 101 113 165 147 40 42 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
110 
disease_progression 
H-positive risk:  692 679 112 1094 400 101 1151 376 141 51 162 41 
H-negative risk:  679 692 1151 1094 376 400 101 112 162 141 41 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
111 
disease_progression 
H-positive risk:  696 684 112 1075 411 99 1145 383 139 49 164 43 
H-negative risk:  684 696 1145 1075 383 411 99 112 164 139 43 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
112 
disease_progression 
H-positive risk:  699 683 110 1077 403 99 1143 388 140 50 165 43 
H-negative risk:  683 699 1143 1077 388 403 99 110 165 140 43 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
113 
disease_progression 
H-positive risk:  700 680 109 1075 410 97 1126 396 142 54 165 46 
H-negative risk:  680 700 1126 1075 396 410 97 109 165 142 46 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
114 
disease_progression 
H-positive risk:  707 682 106 1070 419 99 1121 391 140 52 168 45 
H-negative risk:  682 707 1121 1070 391 419 99 106 168 140 45 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
115 
disease_progression 
H-positive risk:  706 679 108 1073 419 100 1125 390 138 50 165 47 
H-negative risk:  679 706 1125 1073 390 419 100 108 165 138 47 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
116 
disease_progression 
H-positive risk:  711 682 108 1076 411 99 1130 388 134 51 166 44 
H-negative risk:  682 711 1130 1076 388 411 99 108 166 134 44 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
117 
disease_progression 
H-positive risk:  716 683 107 1078 404 101 1134 383 134 50 166 44 
H-negative risk:  683 716 1134 1078 383 404 101 107 166 134 44 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  715 689 108 1080 399 100 1131 381 136 46 167 48 
H-negative risk:  689 715 1131 1080 381 399 100 108 167 136 48 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
119 
disease_progression 
H-positive risk:  719 693 110 1083 397 98 1129 378 135 45 168 45 
H-negative risk:  693 719 1129 1083 378 397 98 110 168 135 45 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
120 
disease_progression 
H-positive risk:  721 693 108 1087 396 93 1132 374 137 44 169 46 
H-negative risk:  693 721 1132 1087 374 396 93 108 169 137 46 44 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
121 
disease_progression 
H-positive risk:  694 652 101 1127 400 91 1165 371 136 44 174 45 
H-negative risk:  652 694 1165 1127 371 400 91 101 174 136 45 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
122 
disease_progression 
H-positive risk:  684 655 101 1122 406 92 1166 370 136 48 175 45 
H-negative risk:  655 684 1166 1122 370 406 92 101 175 136 45 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
123 
disease_progression 
H-positive risk:  694 657 102 1114 406 97 1163 364 134 47 176 46 
H-negative risk:  657 694 1163 1114 364 406 97 102 176 134 46 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  697 656 104 1111 406 96 1171 360 135 46 174 44 
H-negative risk:  656 697 1171 1111 360 406 96 104 174 135 44 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
125 
disease_progression 
H-positive risk:  697 652 102 1112 404 91 1176 363 141 45 174 43 
H-negative risk:  652 697 1176 1112 363 404 91 102 174 141 43 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
126 
disease_progression 
H-positive risk:  692 653 104 1116 404 92 1172 362 143 44 175 43 
H-negative risk:  653 692 1172 1116 362 404 92 104 175 143 43 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
127 
disease_progression 
H-positive risk:  695 663 106 1112 406 92 1160 355 143 45 179 44 
H-negative risk:  663 695 1160 1112 355 406 92 106 179 143 44 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
56 new agents 
128 
disease_progression 
H-positive risk:  690 662 105 1111 410 92 1155 360 145 45 179 46 
H-negative risk:  662 690 1155 1111 360 410 92 105 179 145 46 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
129 
disease_progression 
H-positive risk:  697 656 103 1118 405 89 1154 361 145 48 178 46 
H-negative risk:  656 697 1154 1118 361 405 89 103 178 145 46 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
130 
disease_progression 
H-positive risk:  700 657 103 1112 400 89 1159 363 143 47 181 46 
H-negative risk:  657 700 1159 1112 363 400 89 103 181 143 46 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
131 
disease_progression 
H-positive risk:  705 657 97 1103 402 88 1152 364 148 49 188 47 
H-negative risk:  657 705 1152 1103 364 402 88 97 188 148 47 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
132 
disease_progression 
H-positive risk:  700 656 95 1105 401 87 1150 369 148 50 187 52 
H-negative risk:  656 700 1150 1105 369 401 87 95 187 148 52 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
133 
disease_progression 
H-positive risk:  706 655 97 1115 393 88 1150 362 144 50 188 52 
H-negative risk:  655 706 1150 1115 362 393 88 97 188 144 52 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
134 
disease_progression 
H-positive risk:  707 643 95 1112 407 95 1136 372 141 51 187 54 
H-negative risk:  643 707 1136 1112 372 407 95 95 187 141 54 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
135 
disease_progression 
H-positive risk:  709 642 93 1109 418 95 1133 370 140 49 189 53 
H-negative risk:  642 709 1133 1109 370 418 95 93 189 140 53 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
136 
disease_progression 
H-positive risk:  712 641 94 1114 411 95 1134 372 140 49 183 55 
H-negative risk:  641 712 1134 1114 372 411 95 94 183 140 55 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
137 
disease_progression 
H-positive risk:  706 647 93 1103 421 95 1137 369 142 52 182 53 
H-negative risk:  647 706 1137 1103 369 421 95 93 182 142 53 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
138 
disease_progression 
H-positive risk:  706 644 93 1103 419 93 1139 373 144 50 182 54 
H-negative risk:  644 706 1139 1103 373 419 93 93 182 144 54 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
53 new agents 
139 
disease_progression 
H-positive risk:  699 644 92 1098 420 93 1139 384 145 53 178 55 
H-negative risk:  644 699 1139 1098 384 420 93 92 178 145 55 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
140 
disease_progression 
H-positive risk:  697 642 91 1114 405 94 1144 379 146 53 179 56 
H-negative risk:  642 697 1144 1114 379 405 94 91 179 146 56 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
141 
disease_progression 
H-positive risk:  699 640 89 1110 411 93 1142 385 143 53 181 54 
H-negative risk:  640 699 1142 1110 385 411 93 89 181 143 54 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
142 
disease_progression 
H-positive risk:  694 641 93 1103 414 88 1152 383 146 53 178 55 
H-negative risk:  641 694 1152 1103 383 414 88 93 178 146 55 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
143 
disease_progression 
H-positive risk:  688 637 95 1110 414 90 1152 384 144 56 174 56 
H-negative risk:  637 688 1152 1110 384 414 90 95 174 144 56 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
144 
disease_progression 
H-positive risk:  681 644 97 1103 412 90 1156 384 145 57 174 57 
H-negative risk:  644 681 1156 1103 384 412 90 97 174 145 57 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
145 
disease_progression 
H-positive risk:  685 643 98 1107 410 91 1148 386 145 56 173 58 
H-negative risk:  643 685 1148 1107 386 410 91 98 173 145 58 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
146 
disease_progression 
H-positive risk:  688 640 97 1099 415 91 1138 404 143 57 170 58 
H-negative risk:  640 688 1138 1099 404 415 91 97 170 143 58 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
147 
disease_progression 
H-positive risk:  681 647 96 1095 422 92 1133 411 139 57 169 58 
H-negative risk:  647 681 1133 1095 411 422 92 96 169 139 58 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
148 
disease_progression 
H-positive risk:  693 647 94 1088 421 89 1130 411 142 56 168 61 
H-negative risk:  647 693 1130 1088 411 421 89 94 168 142 61 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 99 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
149 
disease_progression 
H-positive risk:  694 645 93 1096 415 90 1135 406 142 56 167 61 
H-negative risk:  645 694 1135 1096 406 415 90 93 167 142 61 56 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 100 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
150 
disease_progression 
H-positive risk:  698 648 90 1090 416 93 1139 401 139 59 167 60 
H-negative risk:  648 698 1139 1090 401 416 93 90 167 139 60 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
151 
disease_progression 
H-positive risk:  696 641 88 1100 424 95 1134 398 139 58 166 61 
H-negative risk:  641 696 1134 1100 398 424 95 88 166 139 61 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
152 
disease_progression 
H-positive risk:  690 644 91 1097 430 97 1134 394 136 60 165 62 
H-negative risk:  644 690 1134 1097 394 430 97 91 165 136 62 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
153 
disease_progression 
H-positive risk:  686 648 93 1096 432 97 1131 395 139 58 163 62 
H-negative risk:  648 686 1131 1096 395 432 97 93 163 139 62 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
154 
disease_progression 
H-positive risk:  685 650 94 1099 433 97 1137 390 132 60 161 62 
H-negative risk:  650 685 1137 1099 390 433 97 94 161 132 62 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
155 
disease_progression 
H-positive risk:  686 651 91 1096 442 94 1129 394 134 61 162 60 
H-negative risk:  651 686 1129 1096 394 442 94 91 162 134 60 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 99 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
156 
disease_progression 
H-positive risk:  692 654 95 1086 441 93 1123 396 135 61 162 62 
H-negative risk:  654 692 1123 1086 396 441 93 95 162 135 62 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
157 
disease_progression 
H-positive risk:  685 662 93 1086 441 92 1127 390 136 60 165 63 
H-negative risk:  662 685 1127 1086 390 441 92 93 165 136 63 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
158 
disease_progression 
H-positive risk:  675 672 93 1062 453 93 1117 408 140 62 163 62 
H-negative risk:  672 675 1117 1062 408 453 93 93 163 140 62 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
159 
disease_progression 
H-positive risk:  682 670 96 1067 445 92 1110 408 143 62 160 65 
H-negative risk:  670 682 1110 1067 408 445 92 96 160 143 65 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
160 
disease_progression 
H-positive risk:  683 662 95 1064 455 92 1111 409 142 63 156 68 
H-negative risk:  662 683 1111 1064 409 455 92 95 156 142 68 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
161 
disease_progression 
H-positive risk:  680 662 93 1069 454 94 1112 407 142 64 158 65 
H-negative risk:  662 680 1112 1069 407 454 94 93 158 142 65 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
162 
disease_progression 
H-positive risk:  680 664 95 1064 451 95 1102 421 143 64 156 65 
H-negative risk:  664 680 1102 1064 421 451 95 95 156 143 65 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
163 
disease_progression 
H-positive risk:  686 660 94 1056 452 95 1112 415 142 65 158 65 
H-negative risk:  660 686 1112 1056 415 452 95 94 158 142 65 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
164 
disease_progression 
H-positive risk:  687 657 92 1055 453 94 1104 427 147 66 154 64 
H-negative risk:  657 687 1104 1055 427 453 94 92 154 147 64 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
165 
disease_progression 
H-positive risk:  677 658 91 1049 459 92 1105 429 148 69 160 63 
H-negative risk:  658 677 1105 1049 429 459 92 91 160 148 63 69 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
166 
disease_progression 
H-positive risk:  672 663 88 1046 459 91 1103 432 147 67 167 65 
H-negative risk:  663 672 1103 1046 432 459 91 88 167 147 65 67 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
167 
disease_progression 
H-positive risk:  667 668 88 1038 462 90 1101 438 149 67 167 65 
H-negative risk:  668 667 1101 1038 438 462 90 88 167 149 65 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 100 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
168 
disease_progression 
H-positive risk:  670 672 91 1042 452 94 1099 434 149 67 163 67 
H-negative risk:  672 670 1099 1042 434 452 94 91 163 149 67 67 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
169 
disease_progression 
H-positive risk:  665 677 90 1045 453 95 1101 429 150 66 165 64 
H-negative risk:  677 665 1101 1045 429 453 95 90 165 150 64 66 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
101 new agents 
170 
disease_progression 
H-positive risk:  662 681 92 1046 455 96 1092 431 154 65 165 61 
H-negative risk:  681 662 1092 1046 431 455 96 92 165 154 61 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 93 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
171 
disease_progression 
H-positive risk:  658 680 90 1056 452 96 1092 431 151 66 168 60 
H-negative risk:  680 658 1092 1056 431 452 96 90 168 151 60 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
172 
disease_progression 
H-positive risk:  658 683 85 1067 450 96 1089 429 151 64 168 60 
H-negative risk:  683 658 1089 1067 429 450 96 85 168 151 60 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
173 
disease_progression 
H-positive risk:  668 688 82 1058 448 97 1087 428 150 63 170 61 
H-negative risk:  688 668 1087 1058 428 448 97 82 170 150 61 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
174 
disease_progression 
H-positive risk:  679 683 80 1063 447 95 1079 422 153 64 171 64 
H-negative risk:  683 679 1079 1063 422 447 95 80 171 153 64 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
175 
disease_progression 
H-positive risk:  672 682 81 1069 448 96 1082 418 153 62 172 65 
H-negative risk:  682 672 1082 1069 418 448 96 81 172 153 65 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
176 
disease_progression 
H-positive risk:  677 682 81 1064 443 94 1085 421 153 63 172 65 
H-negative risk:  682 677 1085 1064 421 443 94 81 172 153 65 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
177 
disease_progression 
H-positive risk:  672 689 80 1054 451 93 1090 419 152 63 174 63 
H-negative risk:  689 672 1090 1054 419 451 93 80 174 152 63 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
178 
disease_progression 
H-positive risk:  667 695 78 1059 451 92 1096 414 150 61 175 62 
H-negative risk:  695 667 1096 1059 414 451 92 78 175 150 62 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
179 
disease_progression 
H-positive risk:  663 694 75 1059 447 92 1113 414 149 57 177 60 
H-negative risk:  694 663 1113 1059 414 447 92 75 177 149 60 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
180 
disease_progression 
H-positive risk:  661 701 75 1053 445 91 1118 406 150 59 179 62 
H-negative risk:  701 661 1118 1053 406 445 91 75 179 150 62 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
181 
disease_progression 
H-positive risk:  659 703 75 1057 438 90 1124 404 152 59 179 60 
H-negative risk:  703 659 1124 1057 404 438 90 75 179 152 60 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
182 
disease_progression 
H-positive risk:  664 706 74 1050 450 88 1114 409 149 56 178 62 
H-negative risk:  706 664 1114 1050 409 450 88 74 178 149 62 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
183 
disease_progression 
H-positive risk:  662 710 73 1061 440 87 1113 416 151 57 170 60 
H-negative risk:  710 662 1113 1061 416 440 87 73 170 151 60 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
184 
disease_progression 
H-positive risk:  657 706 76 1066 438 88 1118 419 149 54 170 59 
H-negative risk:  706 657 1118 1066 419 438 88 76 170 149 59 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
185 
disease_progression 
H-positive risk:  653 701 76 1061 441 90 1124 423 147 57 168 59 
H-negative risk:  701 653 1124 1061 423 441 90 76 168 147 59 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
186 
disease_progression 
H-positive risk:  652 703 75 1057 443 90 1125 424 144 56 171 60 
H-negative risk:  703 652 1125 1057 424 443 90 75 171 144 60 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
187 
disease_progression 
H-positive risk:  661 700 75 1062 446 91 1117 419 144 55 169 61 
H-negative risk:  700 661 1117 1062 419 446 91 75 169 144 61 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
188 
disease_progression 
H-positive risk:  662 710 81 1054 439 91 1117 420 144 53 167 62 
H-negative risk:  710 662 1117 1054 420 439 91 81 167 144 62 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
189 
disease_progression 
H-positive risk:  671 702 83 1058 441 91 1122 408 145 53 166 60 
H-negative risk:  702 671 1122 1058 408 441 91 83 166 145 60 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
190 
disease_progression 
H-positive risk:  671 705 83 1062 439 92 1117 411 141 54 162 63 
H-negative risk:  705 671 1117 1062 411 439 92 83 162 141 63 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
191 
disease_progression 
H-positive risk:  668 709 83 1042 445 90 1120 415 144 55 165 64 
H-negative risk:  709 668 1120 1042 415 445 90 83 165 144 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
192 
disease_progression 
H-positive risk:  666 704 83 1052 443 88 1123 413 142 58 165 63 
H-negative risk:  704 666 1123 1052 413 443 88 83 165 142 63 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
193 
disease_progression 
H-positive risk:  659 709 84 1059 438 90 1112 411 147 60 168 63 
H-negative risk:  709 659 1112 1059 411 438 90 84 168 147 63 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
194 
disease_progression 
H-positive risk:  666 708 81 1058 439 91 1100 421 145 59 167 65 
H-negative risk:  708 666 1100 1058 421 439 91 81 167 145 65 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
195 
disease_progression 
H-positive risk:  669 706 80 1061 434 88 1101 422 144 62 167 66 
H-negative risk:  706 669 1101 1061 422 434 88 80 167 144 66 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
196 
disease_progression 
H-positive risk:  672 712 80 1054 424 90 1097 430 143 60 168 70 
H-negative risk:  712 672 1097 1054 430 424 90 80 168 143 70 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
197 
disease_progression 
H-positive risk:  672 719 82 1048 419 88 1105 422 150 62 164 69 
H-negative risk:  719 672 1105 1048 422 419 88 82 164 150 69 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
198 
disease_progression 
H-positive risk:  668 719 82 1049 415 90 1109 421 151 62 162 72 
H-negative risk:  719 668 1109 1049 421 415 90 82 162 151 72 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
199 
disease_progression 
H-positive risk:  669 723 80 1056 414 83 1101 425 154 60 162 73 
H-negative risk:  723 669 1101 1056 425 414 83 80 162 154 73 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
200 
disease_progression 
H-positive risk:  670 722 81 1048 415 85 1094 432 162 56 161 74 
H-negative risk:  722 670 1094 1048 432 415 85 81 161 162 74 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
201 
disease_progression 
H-positive risk:  670 721 79 1059 419 82 1092 423 161 57 165 72 
H-negative risk:  721 670 1092 1059 423 419 82 79 165 161 72 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
202 
disease_progression 
H-positive risk:  675 720 80 1068 415 81 1087 420 162 54 165 73 
H-negative risk:  720 675 1087 1068 420 415 81 80 165 162 73 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
203 
disease_progression 
H-positive risk:  679 716 78 1071 413 84 1081 420 159 57 169 73 
H-negative risk:  716 679 1081 1071 420 413 84 78 169 159 73 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
204 
disease_progression 
H-positive risk:  682 715 77 1072 410 88 1074 418 161 56 171 76 
H-negative risk:  715 682 1074 1072 418 410 88 77 171 161 76 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
205 
disease_progression 
H-positive risk:  683 711 77 1090 406 91 1073 414 158 51 170 76 
H-negative risk:  711 683 1073 1090 414 406 91 77 170 158 76 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  686 710 77 1087 409 87 1077 414 158 48 166 81 
H-negative risk:  710 686 1077 1087 414 409 87 77 166 158 81 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
207 
disease_progression 
H-positive risk:  690 711 77 1083 407 88 1069 417 160 48 167 83 
H-negative risk:  711 690 1069 1083 417 407 88 77 167 160 83 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
208 
disease_progression 
H-positive risk:  701 707 76 1084 407 89 1064 415 157 50 167 83 
H-negative risk:  707 701 1064 1084 415 407 89 76 167 157 83 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
94 new agents 
209 
disease_progression 
H-positive risk:  698 699 76 1102 403 89 1050 422 161 50 169 81 
H-negative risk:  699 698 1050 1102 422 403 89 76 169 161 81 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
210 
disease_progression 
H-positive risk:  701 695 77 1103 402 87 1055 425 161 49 166 79 
H-negative risk:  695 701 1055 1103 425 402 87 77 166 161 79 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
211 
disease_progression 
H-positive risk:  695 697 78 1106 398 88 1053 430 166 45 168 76 
H-negative risk:  697 695 1053 1106 430 398 88 78 168 166 76 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
212 
disease_progression 
H-positive risk:  694 698 78 1113 396 90 1046 431 164 46 169 75 
H-negative risk:  698 694 1046 1113 431 396 90 78 169 164 75 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
213 
disease_progression 
H-positive risk:  691 693 81 1113 393 91 1061 422 165 46 170 74 
H-negative risk:  693 691 1061 1113 422 393 91 81 170 165 74 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
214 
disease_progression 
H-positive risk:  686 686 84 1106 395 91 1073 423 163 46 173 74 
H-negative risk:  686 686 1073 1106 423 395 91 84 173 163 74 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
215 
disease_progression 
H-positive risk:  690 682 82 1109 399 92 1076 422 159 45 174 70 
H-negative risk:  682 690 1076 1109 422 399 92 82 174 159 70 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
216 
disease_progression 
H-positive risk:  685 675 83 1095 408 93 1082 426 166 42 174 71 
H-negative risk:  675 685 1082 1095 426 408 93 83 174 166 71 42 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
217 
disease_progression 
H-positive risk:  686 665 85 1097 410 91 1081 432 164 43 176 70 
H-negative risk:  665 686 1081 1097 432 410 91 85 176 164 70 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
94 new agents 
218 
disease_progression 
H-positive risk:  695 663 85 1096 407 90 1082 429 160 45 175 73 
H-negative risk:  663 695 1082 1096 429 407 90 85 175 160 73 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
219 
disease_progression 
H-positive risk:  693 666 87 1084 416 90 1092 424 160 45 172 71 
H-negative risk:  666 693 1092 1084 424 416 90 87 172 160 71 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
220 
disease_progression 
H-positive risk:  694 673 85 1084 413 91 1094 418 160 44 176 68 
H-negative risk:  673 694 1094 1084 418 413 91 85 176 160 68 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
221 
disease_progression 
H-positive risk:  689 678 86 1086 418 91 1086 419 161 45 173 68 
H-negative risk:  678 689 1086 1086 419 418 91 86 173 161 68 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
222 
disease_progression 
H-positive risk:  695 678 89 1081 424 93 1079 415 162 47 168 69 
H-negative risk:  678 695 1079 1081 415 424 93 89 168 162 69 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
223 
disease_progression 
H-positive risk:  696 672 89 1086 422 93 1081 414 164 47 165 71 
H-negative risk:  672 696 1081 1086 414 422 93 89 165 164 71 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
224 
disease_progression 
H-positive risk:  687 667 90 1081 423 92 1087 418 166 51 166 72 
H-negative risk:  667 687 1087 1081 418 423 92 90 166 166 72 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
225 
disease_progression 
H-positive risk:  685 665 89 1076 424 93 1095 422 168 48 164 71 
H-negative risk:  665 685 1095 1076 422 424 93 89 164 168 71 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
226 
disease_progression 
H-positive risk:  687 666 87 1080 420 92 1096 418 168 53 165 68 
H-negative risk:  666 687 1096 1080 418 420 92 87 165 168 68 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
227 
disease_progression 
H-positive risk:  685 663 88 1082 422 91 1089 427 168 50 165 70 
H-negative risk:  663 685 1089 1082 427 422 91 88 165 168 70 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
228 
disease_progression 
H-positive risk:  693 665 91 1084 421 89 1087 426 164 50 161 69 
H-negative risk:  665 693 1087 1084 426 421 89 91 161 164 69 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
229 
disease_progression 
H-positive risk:  686 666 92 1077 426 89 1085 431 161 53 162 72 
H-negative risk:  666 686 1085 1077 431 426 89 92 162 161 72 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
230 
disease_progression 
H-positive risk:  686 669 90 1077 431 88 1090 425 159 54 161 70 
H-negative risk:  669 686 1090 1077 425 431 88 90 161 159 70 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
231 
disease_progression 
H-positive risk:  691 673 89 1075 434 88 1087 426 158 52 156 71 
H-negative risk:  673 691 1087 1075 426 434 88 89 156 158 71 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
232 
disease_progression 
H-positive risk:  689 672 91 1088 430 87 1079 429 156 56 154 69 
H-negative risk:  672 689 1079 1088 429 430 87 91 154 156 69 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
233 
disease_progression 
H-positive risk:  691 675 91 1088 433 86 1077 425 154 55 154 71 
H-negative risk:  675 691 1077 1088 425 433 86 91 154 154 71 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
234 
disease_progression 
H-positive risk:  699 676 92 1080 437 85 1080 422 154 56 149 70 
H-negative risk:  676 699 1080 1080 422 437 85 92 149 154 70 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
235 
disease_progression 
H-positive risk:  704 670 90 1081 434 88 1081 427 154 54 151 66 
H-negative risk:  670 704 1081 1081 427 434 88 90 151 154 66 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
236 
disease_progression 
H-positive risk:  707 670 87 1082 432 89 1094 414 153 53 155 64 
H-negative risk:  670 707 1094 1082 414 432 89 87 155 153 64 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
237 
disease_progression 
H-positive risk:  707 671 86 1069 435 90 1094 423 151 53 158 63 
H-negative risk:  671 707 1094 1069 423 435 90 86 158 151 63 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
238 
disease_progression 
H-positive risk:  709 669 81 1072 434 90 1087 430 149 50 164 65 
H-negative risk:  669 709 1087 1072 430 434 90 81 164 149 65 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 89 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
239 
disease_progression 
H-positive risk:  715 656 83 1069 446 91 1083 432 150 46 163 66 
H-negative risk:  656 715 1083 1069 432 446 91 83 163 150 66 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
240 
disease_progression 
H-positive risk:  721 653 85 1068 443 89 1074 435 153 47 164 68 
H-negative risk:  653 721 1074 1068 435 443 89 85 164 153 68 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
241 
disease_progression 
H-positive risk:  723 661 86 1054 448 89 1059 443 155 48 164 70 
H-negative risk:  661 723 1059 1054 443 448 89 86 164 155 70 48 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 94 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
242 
disease_progression 
H-positive risk:  717 661 83 1059 444 93 1053 452 155 47 164 72 
H-negative risk:  661 717 1053 1059 452 444 93 83 164 155 72 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
243 
disease_progression 
H-positive risk:  722 671 87 1054 442 94 1040 450 152 51 164 73 
H-negative risk:  671 722 1040 1054 450 442 94 87 164 152 73 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
244 
disease_progression 
H-positive risk:  721 670 87 1044 442 94 1039 456 157 51 165 74 
H-negative risk:  670 721 1039 1044 456 442 94 87 165 157 74 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
245 
disease_progression 
H-positive risk:  716 669 89 1046 447 95 1046 449 155 51 165 72 
H-negative risk:  669 716 1046 1046 449 447 95 89 165 155 72 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
246 
disease_progression 
H-positive risk:  712 666 89 1039 454 94 1059 446 153 52 164 72 
H-negative risk:  666 712 1059 1039 446 454 94 89 164 153 72 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
247 
disease_progression 
H-positive risk:  708 669 91 1038 449 92 1066 443 153 53 165 73 
H-negative risk:  669 708 1066 1038 443 449 92 91 165 153 73 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
248 
disease_progression 
H-positive risk:  717 669 90 1036 443 93 1063 449 150 51 166 73 
H-negative risk:  669 717 1063 1036 449 443 93 90 166 150 73 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
249 
disease_progression 
H-positive risk:  713 665 92 1050 436 94 1059 449 153 50 165 74 
H-negative risk:  665 713 1059 1050 449 436 94 92 165 153 74 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  705 662 90 1055 435 93 1069 449 153 49 168 72 
H-negative risk:  662 705 1069 1055 449 435 93 90 168 153 72 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
88 new agents 
251 
disease_progression 
H-positive risk:  700 664 90 1049 442 95 1073 446 154 49 168 70 
H-negative risk:  664 700 1073 1049 446 442 95 90 168 154 70 49 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
252 
disease_progression 
H-positive risk:  690 661 93 1066 433 98 1070 451 150 50 164 74 
H-negative risk:  661 690 1070 1066 451 433 98 93 164 150 74 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
253 
disease_progression 
H-positive risk:  682 656 94 1069 427 95 1077 462 151 50 166 71 
H-negative risk:  656 682 1077 1069 462 427 95 94 166 151 71 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
254 
disease_progression 
H-positive risk:  677 653 96 1071 427 95 1086 460 149 50 165 71 
H-negative risk:  653 677 1086 1071 460 427 95 96 165 149 71 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
255 
disease_progression 
H-positive risk:  677 648 99 1074 419 97 1093 458 147 54 163 71 
H-negative risk:  648 677 1093 1074 458 419 97 99 163 147 71 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 82 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
256 
disease_progression 
H-positive risk:  677 649 100 1070 421 96 1096 456 148 55 162 70 
H-negative risk:  649 677 1096 1070 456 421 96 100 162 148 70 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
257 
disease_progression 
H-positive risk:  676 647 97 1071 424 96 1101 456 144 59 158 71 
H-negative risk:  647 676 1101 1071 456 424 96 97 158 144 71 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
68 new agents 
258 
disease_progression 
H-positive risk:  672 653 98 1069 424 101 1104 449 144 58 158 70 
H-negative risk:  653 672 1104 1069 449 424 101 98 158 144 70 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
259 
disease_progression 
H-positive risk:  669 655 101 1073 416 96 1104 453 144 62 155 72 
H-negative risk:  655 669 1104 1073 453 416 96 101 155 144 72 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
83 new agents 
260 
disease_progression 
H-positive risk:  675 663 100 1072 409 98 1096 454 147 60 154 72 
H-negative risk:  663 675 1096 1072 454 409 98 100 154 147 72 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
261 
disease_progression 
H-positive risk:  679 663 98 1076 407 100 1092 454 146 63 153 69 
H-negative risk:  663 679 1092 1076 454 407 100 98 153 146 69 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
262 
disease_progression 
H-positive risk:  672 667 99 1076 407 98 1093 457 146 64 150 71 
H-negative risk:  667 672 1093 1076 457 407 98 99 150 146 71 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 82 35 

clinical_engagement 
diagnosis 
demography 
73 new agents 
263 
disease_progression 
H-positive risk:  658 662 102 1079 406 95 1097 465 151 64 149 72 
H-negative risk:  662 658 1097 1079 465 406 95 102 149 151 72 64 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 86 37 

clinical_engagement 
diagnosis 
demography 
73 new agents 
264 
disease_progression 
H-positive risk:  659 663 102 1088 405 95 1094 462 150 64 148 70 
H-negative risk:  663 659 1094 1088 462 405 95 102 148 150 70 64 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
265 
disease_progression 
H-positive risk:  654 667 101 1085 408 94 1099 457 152 66 149 68 
H-negative risk:  667 654 1099 1085 457 408 94 101 149 152 68 66 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
266 
disease_progression 
H-positive risk:  658 663 99 1091 411 96 1100 450 155 67 144 66 
H-negative risk:  663 658 1100 1091 450 411 96 99 144 155 66 67 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
99 new agents 
267 
disease_progression 
H-positive risk:  659 666 99 1087 413 101 1101 441 154 70 141 68 
H-negative risk:  666 659 1101 1087 441 413 101 99 141 154 68 70 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
268 
disease_progression 
H-positive risk:  662 670 98 1088 405 101 1099 441 155 69 143 69 
H-negative risk:  670 662 1099 1088 441 405 101 98 143 155 69 69 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
269 
disease_progression 
H-positive risk:  661 673 101 1091 410 100 1094 435 156 70 141 68 
H-negative risk:  673 661 1094 1091 435 410 100 101 141 156 68 70 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
270 
disease_progression 
H-positive risk:  660 669 102 1100 409 100 1092 431 158 71 141 67 
H-negative risk:  669 660 1092 1100 431 409 100 102 141 158 67 71 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
271 
disease_progression 
H-positive risk:  657 658 105 1103 408 102 1089 438 157 71 144 68 
H-negative risk:  658 657 1089 1103 438 408 102 105 144 157 68 71 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
272 
disease_progression 
H-positive risk:  662 655 106 1086 419 103 1089 441 158 71 144 66 
H-negative risk:  655 662 1089 1086 441 419 103 106 144 158 66 71 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
273 
disease_progression 
H-positive risk:  653 657 107 1098 412 103 1096 434 160 70 143 67 
H-negative risk:  657 653 1096 1098 434 412 103 107 143 160 67 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
274 
disease_progression 
H-positive risk:  646 671 107 1081 412 104 1101 440 158 68 145 67 
H-negative risk:  671 646 1101 1081 440 412 104 107 145 158 67 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
275 
disease_progression 
H-positive risk:  647 661 109 1087 423 108 1098 435 156 65 143 68 
H-negative risk:  661 647 1098 1087 435 423 108 109 143 156 68 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
276 
disease_progression 
H-positive risk:  647 657 106 1091 419 106 1101 439 157 65 141 71 
H-negative risk:  657 647 1101 1091 439 419 106 106 141 157 71 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
277 
disease_progression 
H-positive risk:  641 664 107 1087 423 108 1109 429 158 62 140 72 
H-negative risk:  664 641 1109 1087 429 423 108 107 140 158 72 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
95 new agents 
278 
disease_progression 
H-positive risk:  646 659 108 1088 416 109 1118 423 159 62 140 72 
H-negative risk:  659 646 1118 1088 423 416 109 108 140 159 72 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
279 
disease_progression 
H-positive risk:  642 667 109 1083 416 110 1117 421 162 61 140 72 
H-negative risk:  667 642 1117 1083 421 416 110 109 140 162 72 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
280 
disease_progression 
H-positive risk:  639 663 111 1085 415 112 1122 416 161 61 139 76 
H-negative risk:  663 639 1122 1085 416 415 112 111 139 161 76 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
281 
disease_progression 
H-positive risk:  641 657 109 1083 412 113 1120 426 161 63 143 72 
H-negative risk:  657 641 1120 1083 426 412 113 109 143 161 72 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
94 new agents 
282 
disease_progression 
H-positive risk:  645 658 110 1080 414 110 1114 428 158 66 145 72 
H-negative risk:  658 645 1114 1080 428 414 110 110 145 158 72 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
283 
disease_progression 
H-positive risk:  643 665 111 1071 420 113 1106 435 159 64 143 70 
H-negative risk:  665 643 1106 1071 435 420 113 111 143 159 70 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
284 
disease_progression 
H-positive risk:  647 663 107 1074 422 114 1097 435 162 64 148 67 
H-negative risk:  663 647 1097 1074 435 422 114 107 148 162 67 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
285 
disease_progression 
H-positive risk:  647 658 107 1077 420 114 1096 436 160 68 148 69 
H-negative risk:  658 647 1096 1077 436 420 114 107 148 160 69 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
286 
disease_progression 
H-positive risk:  650 656 104 1076 428 112 1090 434 162 67 150 71 
H-negative risk:  656 650 1090 1076 434 428 112 104 150 162 71 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
287 
disease_progression 
H-positive risk:  653 658 101 1076 426 113 1087 431 164 67 153 71 
H-negative risk:  658 653 1087 1076 431 426 113 101 153 164 71 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
288 
disease_progression 
H-positive risk:  656 666 101 1074 424 112 1084 427 165 68 150 73 
H-negative risk:  666 656 1084 1074 427 424 112 101 150 165 73 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
289 
disease_progression 
H-positive risk:  657 669 101 1077 419 113 1081 428 164 70 152 69 
H-negative risk:  669 657 1081 1077 428 419 113 101 152 164 69 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
290 
disease_progression 
H-positive risk:  658 672 101 1065 423 115 1086 427 160 73 151 69 
H-negative risk:  672 658 1086 1065 427 423 115 101 151 160 69 73 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
291 
disease_progression 
H-positive risk:  658 665 101 1077 425 116 1088 420 160 75 149 66 
H-negative risk:  665 658 1088 1077 420 425 116 101 149 160 66 75 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
292 
disease_progression 
H-positive risk:  650 668 105 1079 425 115 1095 417 158 74 149 65 
H-negative risk:  668 650 1095 1079 417 425 115 105 149 158 65 74 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
94 new agents 
293 
disease_progression 
H-positive risk:  659 673 104 1080 418 111 1092 417 159 74 148 65 
H-negative risk:  673 659 1092 1080 417 418 111 104 148 159 65 74 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
294 
disease_progression 
H-positive risk:  652 674 104 1080 418 114 1098 411 156 76 153 64 
H-negative risk:  674 652 1098 1080 411 418 114 104 153 156 64 76 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
295 
disease_progression 
H-positive risk:  647 678 105 1076 421 116 1100 409 154 74 156 64 
H-negative risk:  678 647 1100 1076 409 421 116 105 156 154 64 74 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
296 
disease_progression 
H-positive risk:  653 675 105 1080 428 113 1091 405 155 74 157 64 
H-negative risk:  675 653 1091 1080 405 428 113 105 157 155 64 74 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
297 
disease_progression 
H-positive risk:  654 670 108 1082 423 112 1089 412 157 73 157 63 
H-negative risk:  670 654 1089 1082 412 423 112 108 157 157 63 73 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
298 
disease_progression 
H-positive risk:  656 670 109 1086 418 112 1082 421 155 75 153 63 
H-negative risk:  670 656 1082 1086 421 418 112 109 153 155 63 75 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
299 
disease_progression 
H-positive risk:  664 671 108 1078 417 108 1073 431 153 76 154 67 
H-negative risk:  671 664 1073 1078 431 417 108 108 154 153 67 76 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
300 
disease_progression 
H-positive risk:  662 670 106 1083 417 108 1072 430 154 78 157 63 
H-negative risk:  670 662 1072 1083 430 417 108 106 157 154 63 78 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
301 
disease_progression 
H-positive risk:  663 667 105 1103 409 105 1064 431 153 80 158 62 
H-negative risk:  667 663 1064 1103 431 409 105 105 158 153 62 80 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
106 new agents 
302 
disease_progression 
H-positive risk:  670 681 105 1109 398 107 1058 417 155 78 161 61 
H-negative risk:  681 670 1058 1109 417 398 107 105 161 155 61 78 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
303 
disease_progression 
H-positive risk:  654 684 105 1112 399 108 1069 418 155 78 161 57 
H-negative risk:  684 654 1069 1112 418 399 108 105 161 155 57 78 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
304 
disease_progression 
H-positive risk:  655 674 105 1119 403 108 1053 429 154 78 164 58 
H-negative risk:  674 655 1053 1119 429 403 108 105 164 154 58 78 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
305 
disease_progression 
H-positive risk:  657 668 104 1118 407 110 1050 429 158 76 163 60 
H-negative risk:  668 657 1050 1118 429 407 110 104 163 158 60 76 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
306 
disease_progression 
H-positive risk:  655 664 104 1136 405 111 1043 427 159 74 164 58 
H-negative risk:  664 655 1043 1136 427 405 111 104 164 159 58 74 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
307 
disease_progression 
H-positive risk:  658 670 104 1129 398 110 1042 431 163 71 166 58 
H-negative risk:  670 658 1042 1129 431 398 110 104 166 163 58 71 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
308 
disease_progression 
H-positive risk:  654 668 100 1131 401 104 1048 431 167 69 166 61 
H-negative risk:  668 654 1048 1131 431 401 104 100 166 167 61 69 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
309 
disease_progression 
H-positive risk:  655 671 101 1126 395 103 1051 431 166 70 168 63 
H-negative risk:  671 655 1051 1126 431 395 103 101 168 166 63 70 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 98 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
310 
disease_progression 
H-positive risk:  661 669 102 1125 405 101 1050 427 161 71 167 61 
H-negative risk:  669 661 1050 1125 427 405 101 102 167 161 61 71 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
94 new agents 
311 
disease_progression 
H-positive risk:  670 674 102 1125 396 102 1051 418 162 74 167 59 
H-negative risk:  674 670 1051 1125 418 396 102 102 167 162 59 74 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
312 
disease_progression 
H-positive risk:  675 675 104 1118 400 100 1048 421 162 70 169 58 
H-negative risk:  675 675 1048 1118 421 400 100 104 169 162 58 70 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
313 
disease_progression 
H-positive risk:  672 676 102 1123 404 102 1046 420 164 66 168 57 
H-negative risk:  676 672 1046 1123 420 404 102 102 168 164 57 66 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
314 
disease_progression 
H-positive risk:  670 677 102 1130 406 100 1048 419 165 63 166 54 
H-negative risk:  677 670 1048 1130 419 406 100 102 166 165 54 63 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
315 
disease_progression 
H-positive risk:  666 672 102 1132 399 96 1064 413 169 63 167 57 
H-negative risk:  672 666 1064 1132 413 399 96 102 167 169 57 63 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 97 27 

clinical_engagement 
diagnosis 
demography 
94 new agents 
316 
disease_progression 
H-positive risk:  670 669 102 1126 400 99 1061 418 165 66 167 57 
H-negative risk:  669 670 1061 1126 418 400 99 102 167 165 57 66 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
317 
disease_progression 
H-positive risk:  670 672 104 1133 398 101 1063 411 163 67 164 54 
H-negative risk:  672 670 1063 1133 411 398 101 104 164 163 54 67 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
318 
disease_progression 
H-positive risk:  668 679 105 1129 404 97 1057 414 162 67 162 56 
H-negative risk:  679 668 1057 1129 414 404 97 105 162 162 56 67 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 97 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
319 
disease_progression 
H-positive risk:  676 681 108 1120 409 97 1052 413 162 65 161 56 
H-negative risk:  681 676 1052 1120 413 409 97 108 161 162 56 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
320 
disease_progression 
H-positive risk:  673 678 110 1126 409 97 1059 410 160 64 161 53 
H-negative risk:  678 673 1059 1126 410 409 97 110 161 160 53 64 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
321 
disease_progression 
H-positive risk:  679 679 110 1118 408 96 1058 411 160 62 165 54 
H-negative risk:  679 679 1058 1118 411 408 96 110 165 160 54 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
322 
disease_progression 
H-positive risk:  683 679 108 1117 408 96 1052 414 160 63 165 55 
H-negative risk:  679 683 1052 1117 414 408 96 108 165 160 55 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
323 
disease_progression 
H-positive risk:  685 682 107 1111 412 94 1054 413 164 61 161 56 
H-negative risk:  682 685 1054 1111 413 412 94 107 161 164 56 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
324 
disease_progression 
H-positive risk:  675 685 106 1109 415 96 1059 414 160 62 164 55 
H-negative risk:  685 675 1059 1109 414 415 96 106 164 160 55 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
325 
disease_progression 
H-positive risk:  671 689 106 1103 423 97 1063 410 156 61 164 57 
H-negative risk:  689 671 1063 1103 410 423 97 106 164 156 57 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
326 
disease_progression 
H-positive risk:  667 681 102 1106 427 96 1063 412 155 64 168 59 
H-negative risk:  681 667 1063 1106 412 427 96 102 168 155 59 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
327 
disease_progression 
H-positive risk:  672 676 102 1109 429 99 1069 403 155 63 163 60 
H-negative risk:  676 672 1069 1109 403 429 99 102 163 155 60 63 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
328 
disease_progression 
H-positive risk:  679 670 102 1122 428 98 1058 397 158 61 166 61 
H-negative risk:  670 679 1058 1122 397 428 98 102 166 158 61 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
329 
disease_progression 
H-positive risk:  676 671 103 1114 431 98 1057 400 161 64 162 63 
H-negative risk:  671 676 1057 1114 400 431 98 103 162 161 63 64 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
330 
disease_progression 
H-positive risk:  671 670 102 1115 426 97 1068 404 160 66 158 63 
H-negative risk:  670 671 1068 1115 404 426 97 102 158 160 63 66 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 100 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
331 
disease_progression 
H-positive risk:  667 668 101 1127 417 97 1070 406 158 68 156 65 
H-negative risk:  668 667 1070 1127 406 417 97 101 156 158 65 68 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 100 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
332 
disease_progression 
H-positive risk:  664 667 102 1126 415 99 1080 396 159 68 156 68 
H-negative risk:  667 664 1080 1126 396 415 99 102 156 159 68 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
333 
disease_progression 
H-positive risk:  666 666 101 1125 421 102 1074 400 158 66 156 65 
H-negative risk:  666 666 1074 1125 400 421 102 101 156 158 65 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
334 
disease_progression 
H-positive risk:  670 664 102 1115 421 104 1070 405 157 67 161 64 
H-negative risk:  664 670 1070 1115 405 421 104 102 161 157 64 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
335 
disease_progression 
H-positive risk:  669 661 105 1118 417 104 1072 411 154 65 159 65 
H-negative risk:  661 669 1072 1118 411 417 104 105 159 154 65 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
336 
disease_progression 
H-positive risk:  673 661 103 1126 416 107 1063 411 148 66 165 61 
H-negative risk:  661 673 1063 1126 411 416 107 103 165 148 61 66 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
337 
disease_progression 
H-positive risk:  684 665 104 1125 414 108 1066 401 143 66 165 59 
H-negative risk:  665 684 1066 1125 401 414 108 104 165 143 59 66 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
338 
disease_progression 
H-positive risk:  684 660 105 1138 413 110 1065 393 141 68 165 58 
H-negative risk:  660 684 1065 1138 393 413 110 105 165 141 58 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
339 
disease_progression 
H-positive risk:  689 659 107 1130 424 101 1062 391 142 70 168 57 
H-negative risk:  659 689 1062 1130 391 424 101 107 168 142 57 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
340 
disease_progression 
H-positive risk:  682 655 105 1131 417 98 1058 408 145 73 170 58 
H-negative risk:  655 682 1058 1131 408 417 98 105 170 145 58 73 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
341 
disease_progression 
H-positive risk:  683 662 106 1124 412 99 1062 407 148 73 163 61 
H-negative risk:  662 683 1062 1124 407 412 99 106 163 148 61 73 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
342 
disease_progression 
H-positive risk:  679 660 106 1128 412 96 1064 411 149 73 163 59 
H-negative risk:  660 679 1064 1128 411 412 96 106 163 149 59 73 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
343 
disease_progression 
H-positive risk:  678 663 106 1133 412 94 1050 419 151 71 166 57 
H-negative risk:  663 678 1050 1133 419 412 94 106 166 151 57 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
344 
disease_progression 
H-positive risk:  683 661 106 1127 410 89 1057 418 153 69 167 60 
H-negative risk:  661 683 1057 1127 418 410 89 106 167 153 60 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
345 
disease_progression 
H-positive risk:  672 656 105 1130 408 88 1065 425 154 69 169 59 
H-negative risk:  656 672 1065 1130 425 408 88 105 169 154 59 69 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
346 
disease_progression 
H-positive risk:  682 658 106 1135 403 87 1064 421 151 69 166 58 
H-negative risk:  658 682 1064 1135 421 403 87 106 166 151 58 69 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
347 
disease_progression 
H-positive risk:  676 658 107 1140 399 88 1070 418 152 70 163 59 
H-negative risk:  658 676 1070 1140 418 399 88 107 163 152 59 70 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
348 
disease_progression 
H-positive risk:  674 667 105 1136 401 85 1064 414 155 74 168 57 
H-negative risk:  667 674 1064 1136 414 401 85 105 168 155 57 74 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
349 
disease_progression 
H-positive risk:  680 668 105 1141 397 85 1058 412 154 73 169 58 
H-negative risk:  668 680 1058 1141 412 397 85 105 169 154 58 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
350 
disease_progression 
H-positive risk:  679 670 106 1144 395 81 1047 417 161 72 167 61 
H-negative risk:  670 679 1047 1144 417 395 81 106 167 161 61 72 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
351 
disease_progression 
H-positive risk:  674 670 105 1137 399 83 1048 423 158 73 163 67 
H-negative risk:  670 674 1048 1137 423 399 83 105 163 158 67 73 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
352 
disease_progression 
H-positive risk:  671 673 102 1135 396 82 1051 428 155 74 166 67 
H-negative risk:  673 671 1051 1135 428 396 82 102 166 155 67 74 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
54 new agents 
353 
disease_progression 
H-positive risk:  669 670 103 1134 402 81 1048 428 159 71 168 67 
H-negative risk:  670 669 1048 1134 428 402 81 103 168 159 67 71 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
354 
disease_progression 
H-positive risk:  667 679 102 1142 394 79 1055 423 157 68 168 66 
H-negative risk:  679 667 1055 1142 423 394 79 102 168 157 66 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
355 
disease_progression 
H-positive risk:  669 673 100 1150 392 80 1048 427 157 70 170 64 
H-negative risk:  673 669 1048 1150 427 392 80 100 170 157 64 70 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
356 
disease_progression 
H-positive risk:  660 678 103 1147 391 79 1053 429 157 69 171 63 
H-negative risk:  678 660 1053 1147 429 391 79 103 171 157 63 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
97 new agents 
357 
disease_progression 
H-positive risk:  664 686 102 1144 386 78 1049 426 163 67 171 64 
H-negative risk:  686 664 1049 1144 426 386 78 102 171 163 64 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
358 
disease_progression 
H-positive risk:  663 682 101 1149 388 78 1047 426 165 68 170 63 
H-negative risk:  682 663 1047 1149 426 388 78 101 170 165 63 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
359 
disease_progression 
H-positive risk:  670 671 101 1155 390 78 1039 430 163 71 167 65 
H-negative risk:  671 670 1039 1155 430 390 78 101 167 163 65 71 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
360 
disease_progression 
H-positive risk:  670 676 99 1145 391 81 1040 428 166 70 169 65 
H-negative risk:  676 670 1040 1145 428 391 81 99 169 166 65 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
Time difference of 17.34173 mins
This is task 17
date
